Добірка наукової літератури з теми "Gestational glucose intolerance"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Gestational glucose intolerance".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Gestational glucose intolerance"
Szlapinski, Sandra K., Anthony A. Botros, Sarah Donegan, Renee T. King, Gabrielle Retta, Brenda J. Strutt, and David J. Hill. "Altered pancreas remodeling following glucose intolerance in pregnancy in mice." Journal of Endocrinology 245, no. 2 (May 2020): 315–26. http://dx.doi.org/10.1530/joe-20-0012.
Повний текст джерелаSutherland, H. W., D. W. M. Pearson, and F. A. Van Assche. "SCREENING FOR GESTATIONAL GLUCOSE INTOLERANCE." Lancet 334, no. 8655 (July 1989): 153–54. http://dx.doi.org/10.1016/s0140-6736(89)90202-x.
Повний текст джерелаCorrado, F., F. Caputo, G. Facciola, and A. Mancuso. "Gestational Glucose Intolerance in Multiple Pregnancy." Diabetes Care 26, no. 5 (May 1, 2003): 1646. http://dx.doi.org/10.2337/diacare.26.5.1646.
Повний текст джерелаMuche, Achenef Asmamaw, Oladapo O. Olayemi, and Yigzaw Kebede Gete. "Predictors of postpartum glucose intolerance in women with gestational diabetes mellitus: a prospective cohort study in Ethiopia based on the updated diagnostic criteria." BMJ Open 10, no. 8 (August 2020): e036882. http://dx.doi.org/10.1136/bmjopen-2020-036882.
Повний текст джерелаVarillas, Dora, and VF Varillas. "Early glucose intolerance postpartum of gestational diabetes associated with overload test with 50 grams of glucose." Problems of Endocrinology 62, no. 5 (September 22, 2016): 30–31. http://dx.doi.org/10.14341/probl201662530-31.
Повний текст джерелаBajaj, Harpreet S., Chang Ye, Anthony J. Hanley, Mathew Sermer, Bernard Zinman, and Ravi Retnakaran. "Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancy." Diabetes and Vascular Disease Research 15, no. 5 (June 5, 2018): 449–57. http://dx.doi.org/10.1177/1479164118779924.
Повний текст джерелаMladenovic, Violeta, Milica Dimitrijevic-Stojanovic, Djuro Macut, and Aleksandar Djukic. "Glycoregulation During Pregnancy." Serbian Journal of Experimental and Clinical Research 20, no. 2 (June 1, 2019): 9–16. http://dx.doi.org/10.1515/sjecr-2017-0009.
Повний текст джерелаBEN-ZIV, RINAT GABBAY, and MOSHE HOD. "GESTATIONAL DIABETES MELLITUS." Fetal and Maternal Medicine Review 19, no. 3 (August 2008): 245–69. http://dx.doi.org/10.1017/s0965539508002234.
Повний текст джерелаChampion, Macie L., Ashley N. Battarbee, Joseph R. Biggio, Brian M. Casey, and Lorie M. Harper. "Postpartum glucose intolerance following early gestational diabetes mellitus." American Journal of Obstetrics & Gynecology MFM 4, no. 3 (May 2022): 100609. http://dx.doi.org/10.1016/j.ajogmf.2022.100609.
Повний текст джерелаPetry, Clive J. "Nutrition for Gestational Diabetes—Progress and Potential." Nutrients 12, no. 9 (September 3, 2020): 2685. http://dx.doi.org/10.3390/nu12092685.
Повний текст джерелаДисертації з теми "Gestational glucose intolerance"
Dawson, Shelagh I. "Gestational glucose intolerance : the long-term implications." Thesis, University of Aberdeen, 2001. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU142009.
Повний текст джерелаZein, Salam. "Evaluation de l'implication d'un statut martial élevé durant la gestation sur le risque de stress oxydant et de diabète gestationnel." Thesis, Grenoble, 2014. http://www.theses.fr/2014GRENS014/document.
Повний текст джерелаThe overall goal of this study was to establish the role of ferritin as a predictor for gestational diabetes mellitus and oxidative stress in non-anemic and non-iron supplemented Lebanese women. We observed that high ferritin level during the first-trimester of pregnancy was a predictor for impaired glucose tolerance, whereas high hemoglobin values yielded no significant relationship, suggesting that the iron reserve was the main indicator to be considered as a risk factor rather than the functional iron. Thus, the serum ferritin level could be used as a biological marker to assess for the risk of glucose intolerance in pregnant women. Based on the new World Health Organization criteria for gestational diabetes mellitus diagnosis, it is predicted that gestational diabetes mellitus prevalence in our population could be increased by four-fold. Since gestational diabetes mellitus has deleterious effects on the perinatal and maternal health outcomes, the implementation of these new criteria will allow for better management of blood glucose in pregnant women at risk for developing gestational diabetes mellitus. Although the new criteria adopted lower cut-off blood glucose value, hyperglycemia is still a factor that highly associated with increase oxidative stress, ultimately leading to DNA damage. Previously, we have shown that high iron status was associated with elevated oxidative stress. Furthermore, we have established that high ferritin during early-term pregnancy affected the association between oxidative stress and insulin resistance with glucose intolerance. Due to the lack of good experimental model to study gestational diabetes mellitus, we have utilized fructose-supplemented diet fed pregnant dam as an experimental animal model for our gestational diabetes studies. Data obtained in a preliminary study indicated that, this experimental animal model had identical metabolic modifications found in women with gestational diabetes mellitus. Moreover, we have showed that iron-enriched diet significantly increased the redox status of the brain and the liver of the fructose-supplemented dams. Therefore, we believed that this experimental model is good model for future studies to evaluate the signaling pathways involved in iron, oxidative stress and gestational diabetes and to assess the impact of increased oxidative damage during pregnancy on the fetus, immediately after birth and later during the developmental stages via various behavioral tests. Finally, an epigenetic study using this experimental model may allow us to understand the genetic alterations that affected the likelihood of developing insulin resistance, diabetes, or cognitive decline in pups born to the mothers with gestational diabetes. Based on the findings from our studies on the interaction between ferritin, glucose impairment, and oxidative stress, as well as the iron-supplemented diet in the dams with gestational diabetes mellitus, a caution must be exercised when supplementing a pregnant woman with iron. The use of iron-supplementation during pregnancy should be re-evaluated
Sapienza, Andréia David. "Fatores preditores do uso de insulina em pacientes com diabetes melito gestacional diagnosticado pelo teste de tolerância à glicose oral de 100 gramas." Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/5/5139/tde-29042009-132253/.
Повний текст джерелаObjective: To determine the association between clinical and laboratory parameters and insulin requirement in pregnancies complicated by gestational diabetes mellitus (GDM), and to evaluate possible factors predicting the need for insulin therapy. Methods: A total of 294 patients with GDM diagnosed by the 100- g/3-h oral glucose tolerance test (OGTT) between 24 and 33 complete weeks of gestation were retrospectively studied. These patients were under prenatal follow-up at the Obstetric Clinic of the University of Sao Paulo School of Medicine (HCFMUSP) between July 1, 2002 and June 30, 2008. The clinical and laboratory factors which could be associated to the need for insulin therapy were analyzed: maternal age, prepregnancy obesity body mass index (BMI) > 30 Kg/m2, family history of diabetes mellitus (DM), smoking, hypertension, use of systemic corticosteroids, prior GDM, prior fetal macrosomia, nulliparity, multiparity, prior stillbirth, prior neonatal death, gestational age at diagnosis of GDM, multiple pregnancy, elevated amniotic fluid index (AFI) AFI > 18 cm, polyhydramnios (AFI > 25 cm), number of abnormal 100-g/3-h OGTT values, 100-g/3-h OGTT fasting plasma glucose > 95 mg/dL, mean of the four 100-g/3-h OGTT values, 100-g/3-h OGTT fasting/one/two/three plasma glucose values, and glycated hemoglobin (HbA1c). The association between each factor and the need for insulin therapy was then analyzed individually (Pearsons chi-square/Fishers exact or Student t test). The performance of these factors to predict the probability of insulin therapy was estimated using a logistic regression model. Results: Among the 294 patients studied, 39.8% (117/294) required insulin for glycemic control. Univariate analysis showed a positive correlation between insulin therapy and prepregnancy obesity, family history of diabetes, hypertension, prior GDM, prior fetal macrosomia, number of abnormal 100-g/3-h OGTT values, 100-g/3-h OGTT fasting plasma glucose > 95 mg/dL, mean of the four 100-g/3-h OGTT values, 100-g/3-h OGTT fasting/one/two/three plasma glucose values, and HbA1c (P < 0.05). Two logistic regression models were developed and included the following parameters: prepregnancy obesity, family history of diabetes, number of abnormal 100-g/3-h OGTT values (just model 1) and 100-g/3-h OGTT fasting plasma glucose (just model 2). The two first models were analysed another time including the variable HbA1c to verify its contribution on prediction of the need for insulin therapy. Probability curves and scores were constructed based on the four combinations of predictive factors. Conclusions: The probability of insulin therapy can be estimated in pregnant women with GDM based on prepregnancy obesity, family history of diabetes, number of abnormal 100-g/3-h OGTT values, 100-g/3-h OGTT fasting plasma glucose, and HbA1c concentration.
Schlüter, Amelie. "Veränderungen des Kohlenhydratstoffwechsels im Leben einer Frau und seine Bedeutung für den Frauenarzt." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2005. http://dx.doi.org/10.18452/15238.
Повний текст джерелаThe aim of this comparative review is to reveal the current standard of knowledge concerning carbohydrate metabolism in women. The study demonstrates the physiological changes in metabolism at various stages in a female life, from childhood and puberty, through menstruation and pregnancy and ending with the menopause, whilst also evaluating different causes and possible mechanisms that lead to aberrance in insulin resistance and insulin secretion and thereby potentially to glucose intolerance and/or type 2 Diabetes mellitus. In addition to presenting physiological alterations in glucose metabolism, this work also analyses changes generated by iatrogenic treatment such as oral contraceptives and hormone replacement therapy, as well as those caused by different pathologies like polycystic ovary syndrome or gestational diabetes. The results indicate a strong correlation between the female reproduction system and the carbohydrate metabolism. The interaction is influenced by the many very different factors. Before prescribing oral contraceptives, hormone replacement therapy in climacteric (especially during the treatment of infertility in PCOS), or examining patients, the gynaecologist needs to be aware of the fact that different phases in life along with sex steroids and connected changes in the reproductive system, might lead to severe metabolic diversifications. Special attention should be paid to an increased insulin resistance, associated with an augmentation in insulin secretion. Not only the metabolic syndrome, the simultaneous appearance of metabolic abnormalities (dyslipidaemia, insulin resistance, adiposity, hypertonia), which holds a higher risk of cardiovascular diseases, especially arteriosclerosis, but also the consequential increased prevalence of type 2 diabetes mellitus and the highly increased prevalence of adiposity, demand for a multidisciplinary collaboration between gynaecologists and internists.
Maftei, Oana. "Intrauterine influences on obesity and insulin resistance in pre-pubertal children." Thesis, 2012. http://hdl.handle.net/2440/75507.
Повний текст джерелаThesis (Ph.D.) -- University of Adelaide, School of Population Health and Clinical Practice and School of Paediatrics and Reproductive Health, 2012
Частини книг з теми "Gestational glucose intolerance"
Brunetti, Antonio, Ida Pastore, Rossella Liguori, and Eusebio Chiefari. "Postpartum Glucose Intolerance in Gestational Diabetes." In Nutrition and Diet in Maternal Diabetes, 303–15. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56440-1_24.
Повний текст джерелаJones, Bryony, and Anne Dornhorst. "Diabetes in pregnancy." In Oxford Textbook of Medicine, edited by Catherine Nelson-Piercy, 2627–37. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0272.
Повний текст джерелаBanerjee, Samar. "Biomarkers in GDM, Role in Early Detection and Prevention." In Gestational Diabetes Mellitus - New Developments. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.100563.
Повний текст джерелаPhillips, Anne, and Roger Gadsby. "Understanding Diabetes Mellitus." In Adult Nursing Practice. Oxford University Press, 2012. http://dx.doi.org/10.1093/oso/9780199697410.003.0019.
Повний текст джерелаSia-Atanacio, Aileen Yu, Aimee Andag-Silva, and Elaine Cheeay Cunanan. "Incidence of Postpartum Diabetes and Glucose Intolerance among Women with Gestational Diabetes Mellitus Seen at University of Santo Tomas Hospital — A Preliminary Study." In CLINICAL - Miscellaneous Topics in Diabetes, P1–523—P1–523. The Endocrine Society, 2011. http://dx.doi.org/10.1210/endo-meetings.2011.part2.p10.p1-523.
Повний текст джерела